Posts

Showing posts with the label Medical Foods Market 2028

What to Know About Medical Foods ?

Image
  What is a medical food product? I am starting this journey to “understanding medical food product” with a most commonly asked question. Well, we have already discussed the basic meaning of  medical food  above. Now, let’s just listen to what Orphan Drug Act by the U.S. Food and Drug Administration (FDA) has to say. As per the act “a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation”. If we break it down, medical food has three prime characteristics: It involves such foods that meet  distinctive nutritional requirements  of an illness which can’t be met by dietary supplements. For example, Lunglaid is a medical food that is given to patients suffering from chronic asthma. It should be consumed/administered  orally  under th

Medical Foods Market Size To Hit USD 30.34 Billion By 2028

Image
  San Francisco, 22 April 2021:   The Report  Medical Foods Market  Size, Share & Trends Analysis Report By Route Of Administration, By Product (Pills, Powder), By Application, By Sales Channel, By Region, And Segment Forecasts, 2021 - 2028 The global medical foods market size is anticipated to reach USD 30.34 billion by 2028 according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% over the forecast period. Factors such as the growing prevalence of chronic conditions along with the increasing geriatric population adopting medical foods are positively impacting the growth. Rising awareness regarding clinical nutrition among healthcare professionals and patients is projected to further bolster the growth over the forecast period. Based on the route of administration, oral administration dominated the market in 2020. Factors contributing to the high share include high commercial viability of orally administered products and high preference for